Australian Government: Australian Institute of Health and Welfare METeOR Home Page

Cancer staging—cancer staging scheme source, code N[N]

Identifying and definitional attributes

Metadata item type:Help on this termData Element
Short name:Help on this termStaging scheme source
METeOR identifier:Help on this term393364
Registration status:Help on this termHealth, Standard 07/12/2011
Definition:Help on this termThe reference which describes in detail the methods of staging and the definitions for the classification system used in determining the extent of cancer, as represented by a code.
Data Element Concept:Cancer staging—cancer staging scheme source

Value domain attributes

Representational attributes

Representation class:Help on this termCode
Data type:Help on this termNumber
Format:Help on this termN[N]
Maximum character length:Help on this term2
Permissible values:Help on this term
ValueMeaning
1TNM Classification of Malignant Tumours (UICC)
2Durie & Salmon for multiple myeloma staging
3French-American-British (FAB) for leukaemia classification
4Australian Clinico-Pathological Staging (ACPS) System for colorectal cancer
5International Federation of Gynecologists & Obstetricians (FIGO) for gynaecological cancers
6Dukes/Modified Dukes for colorectal cancer
7Ann Arbor staging system for lymphomas
8Binet Staging Classification for chronic lymphocytic leukaemia
9Rai staging system for chronic lymphocytic leukaemia
10Chronic Myeloid Leukaemia (CML) staging system
11International Staging System (ISS) for myeloma
12American Joint Committee on Cancer (AJCC) Cancer Staging Manual
96Other reference
Supplementary values:Help on this term
97Not applicable
98Unknown
99Not stated/inadequately described

Collection and usage attributes

Guide for use:Help on this term

CODE 10   Chronic Myeloid Leukaemia (CML) staging system

Criteria for diagnosing the transition from the chronic phase into the accelerated phase in patients with Chronic Myeloid Leukaemia (CML) is variable. The WHO criteria (Vardiman et al. 2002) are perhaps the most widely used and are recommended.

Source and reference attributes

Reference documents:Help on this term

American Joint Committee on Cancer 2010. AJCC Cancer Staging Manual, 7th edition. Springer: New York

Astler VB & Coller FA 1954. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139:846

Australian Cancer Network Colorectal Cancer Guidelines Revision Committee 2005. Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. Sydney: The Cancer Council Australia and Australian Cancer Network

Benedet JL & Pecorelli S 2000. Staging classifications and clinical practice guidelines of gynaecologic cancers. FIGO Committee on Gynaecologic Oncology

Bennett JM et al. 1985. Proposed revised criteria for the classification of acute myeloid leukaemia. French-American-British (FAB) co-operative group. Ann Intern Med 103(4):620-625

Binet JL et al. 1981. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198-206

Binet JL et al. 1981. Proposals for a revised staging system. Br J Haematol 48:365-7

Carbone PA, Kaplan HS, Musshoff K, Smithers, DW, Tubiana M 1971. Report of the committee on Hodgkin’s disease staging classification. Cancer Research 31:1860-1861

Davis NC & Newland RC 1983. The reporting of colorectal cancer: the Australian Clinico-pathological Staging (ACPS) System. Med J Aust 1(6):282

Dukes CE 1932. The classification of cancer of the rectum. J Pathol Bacteriol 35:323

Durie BG & Salmon SE 1975. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36(3):842-54

Greipp PR et al. 2005. International Staging System for Multiple Myeloma. J Clin Oncol 23(15):3412-20

International Myeloma Working Group 2003. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 121:749-757

Lister TA et al. 1989. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol 7(11):1630-6

Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN 1975. Clinical staging of chronic lymphocytic leukaemia. Blood 46(2):219-34

Rosenberg SA 1977. Validity of the Ann Arbor staging classification for the non-Hodgkin’s lymphomas. Cancer Treat Rev 61:1023-27

Sobin LH, Gospodarowicz MK, Wittekind C (Editors) 2009. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours, 7th edition. Wiley-Blackwell

Vardiman JW, Harris NL, Brunning RD 2002. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100(7):2292-2302 

Data element attributes

Collection and usage attributes

Guide for use:Help on this term

It is recommended that the TNM Classification of Malignant Tumours (International Union Against Cancer (UICC)) or the American Joint Committee on Cancer (AJCC) Cancer Staging Manual be used whenever it is applicable. The classifications published in the AJCC Cancer Staging Manual are identical to the TNM classifications of the UICC.

TNM is not applicable to all tumour sites. Staging is of limited use in some cancers, for example, haematological malignancies. In these cases use the most appropriate classification system.

The Cancer Council Australia and Australian Cancer Network Guidelines for the prevention, early detection and management of colorectal cancer (2005, pp. 159-162) support the use of the Australian Clinico-Pathological Staging (ACPS) System. They recommend that both TNM and ACPS staging data be recorded to enable national and international comparisons. A table of correspondences between ACPS and TNM classifications is available.

The current edition of each staging scheme should be used.

Comments:Help on this termCollected to identify which classification system is used to determine the extent of cancer at the time of diagnosis. Cancer stage is an important determinant of treatment and prognosis, and is used to evaluate new treatments and analyse outcomes. Survival analysis is adjusted by stage at diagnosis and distribution of cancer cases by type and stage.

Source and reference attributes

Submitting organisation:Help on this termCancer Australia
Origin:Help on this term

International Union Against Cancer (UICC)

FAB (French-American-British) Group

NSW Health Department

National Health & Medical Research Council

Clinical Oncological Society of Australia

Australian Cancer Network

Relational attributes

Related metadata references:Help on this term

See also Cancer staging—cancer staging scheme source edition number, code N[N] Health, Standard 07/12/2011

Supersedes Cancer staging—cancer staging scheme source, code N Health, Superseded 07/12/2011

See also Person with cancer—extent of primary cancer, stage grouping other, code X[XXXXX] Health, Standard 07/12/2011

Implementation in Data Set Specifications:Help on this term
All attributes +

Bowel cancer diagnosed cluster Health, Superseded 06/09/2018

DSS specific attributes +

Bowel cancer diagnosed cluster Health, Standard 06/09/2018

DSS specific attributes +

Cancer (clinical) DSS Health, Superseded 08/05/2014

Cancer (clinical) DSS Health, Superseded 14/05/2015

Cancer (clinical) NBPDS Health, Standard 14/05/2015

Implementation in Indicators:Help on this termUsed as numerator
National Bowel Cancer Screening Program: PI 08-Cancer clinico-pathological stage distribution Health, Superseded 06/09/2018
National Bowel Cancer Screening Program: PI 08-Cancer clinico-pathological stage distribution Health, Standard 06/09/2018
My items Help on this term
Download Help on this term